Thrombopoietin: the novel hepatic hormone.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  News in Physiological Sciences - NIPS

• Publication date

  2002-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/PHYSIOLOGYONLINE.2002.17.1.6PMID 11821529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of the liver in the production of thrombopoietin compared with erythropoietin.

  2001cited by this paper
• Subcellular localization of thrombopoietin in human blood platelets and its release upon thrombin stimulation

  2001cited by this paper
• The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization.

  2000cited by this paper
• Interleukin-6 Increases Thrombopoietin Production in Human Hepatoma Cells HepG2 and Hep3B

  2000cited by this paper
• Coagulation and bleeding disorders: review and update.

  2000cited by this paper
• The role of platelet alpha-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells.

  2000cited by this paper
• Biologic and structural differences of thrombopoietic growth factors.

  2000cited by this paper
• The role of platelet α-granular proteins in the regulation of thrombopoietin messenger RNA expression in human bone marrow stromal cells

  2000cited by this paper
• Interaction of thrombopoietin with the platelet c‐mpl receptor in plasma: binding, internalization, stability and pharmacokinetics

  1999cited by this paper
• Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood

  1999cited by this paper
• Expression of the thrombopoietin gene in human fetal and neonatal tissues.

  1999cited by this paper
• Primary role of the liver in thrombopoietin production shown by tissue-specific knockout.

  1998cited by this paper
• Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin.

  1998cited by this paper
• Hematopoietic Deficiencies in c‐mpl and TPO Knockout Mice

  1998cited by this paper
• Thrombopoietin.

  1998cited by this paper
• Cytokines, platelet production and hemostasis.

  1997cited by this paper
• Thrombopoietin Levels in Patients with Cirrhosis before and after Orthotopic Liver Transplantation

  1997cited by this paper
• The role of platelets in antimicrobial host defense.

  1997cited by this paper
• Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization.

  1997cited by this paper
• Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.

  1996cited by this paper
• The Origin and Nature of the Blood Plates

  1906cited by this paper

• Identification of Active Molecules against Thrombocytopenia through Machine Learning

  2024cites this paper
• Review on the Biogenesis of Platelets in Lungs and Its Alterations in SARS-CoV-2 Infection Patients

  2023cites this paper
• Neonatal Thrombocytopenia as a Presenting Finding in de novo Pyruvate Kinase Deficiency

  2023cites this paper
• Is it possible to predict Surgical Site Infection?

  2023cites this paper
• Pro106Leu MPL mutation is associated with thrombocytosis and a low risk of thrombosis, splenomegaly and marrow fibrosis

  2022cites this paper
• Thrombocytosis and abnormal liver enzymes: A trigger for investigation of underlying malignancy

  2022cites this paper
• The Role of Preoperative Platelet-to-Lymphocyte Ratio as a Predictor for Incisional Hernias after Hand-Assisted Laparoscopic Liver Surgery for Metastatic Colorectal Cancer

  2022cites this paper
• Hemostasis testing in patients with liver dysfunction: Advantages and caveats

  2021cites this paper
• Development and validation of a novel reporter gene assay for determination of recombinant human thrombopoietin.

  2021cites this paper
• Real-life experience with avatrombopag

  2021cites this paper
• Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy

  2021cites this paper
• Photobiomodulation therapy for thrombocytopenia by upregulating thrombopoietin expression via the ROS‐dependent Src/ERK/STAT3 signaling pathway

  2021cites this paper
• Hereditary thrombocytosis: the genetic landscape

  2021cites this paper
• Improvement of platelet in thrombocytopenic HCV patients after treatment with direct-acting antiviral agents and its relation to outcome

  2020cites this paper
• ASSOCIATION OF LIVER FUNCTION TEST PARAMETERS WITH HEMATOLOGICAL INDICES IN SEROPOSITIVE HEPATITIS B PATIENTS

  2020cites this paper
• A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 Diabetes

  2020cites this paper
• Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study

  2020cites this paper
• Management of Thrombocytopenia in Patients with Chronic Liver Disease

  2019cites this paper
• Mechanisms and therapeutic prospects of thrombopoietin receptor agonists.

  2019cites this paper
• Thrombocytopenia in Healthy Term Infants: Incidence and Clinical Outcomes at Middlemore Hospital, New Zealand

  2019cites this paper
• Evaluating the Role of Janus Kinase Pathways in Platelet Homeostasis Using a Systems Modeling Approach

  2019cites this paper
• Treatment with direct‐acting antiviral agents is associated with increased platelet count in patients with chronic hepatitis C

  2019cites this paper
• A network map of thrombopoietin signaling

  2018cites this paper
• Results, Discussion, and Conclusion

  2018cites this paper
• Rôle de la MAP kinase p38α au cours d'une agression aiguë du foie

  2018cites this paper
• Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as predictors of wound healing failure in head and neck reconstruction

  2017cites this paper
• Platelets in liver disease, cancer and regeneration

  2017cites this paper
• Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO‐R Agonist, in Healthy Individuals

  2017cites this paper
• Trombinol, a bioactive fraction of Psidium guajava, stimulates thrombopoietin expression in HepG2 cells

  2017cites this paper
• Platelet‐to‐lymphocyte ratio (PLR) and neutrophil‐to‐lymphocyte ratio (NLR) are associated with chronic hepatitis B virus (HBV) infection

  2017cites this paper
• Advances in the pathophysiology of primary immune thrombocytopenia

  2017cites this paper
• Evaluación de los factores determinantes del recuento de plaquetas en pacientes con cirrosis

  2016influential citation
• Platelet count control in immune thrombocytopenic purpura patient: optimum romiplostim dose profile

  2016cites this paper
• Immunohistochemical Analysis of Platelet Extract Effects on Liver Injury Induced by CCl4 in Male Rats

  2016cites this paper
• Novel functions of platelets in the liver

  2016cites this paper
• Myeloproliferative Syndromes and Thrombocythemia

  2016cites this paper
• An engineering control system paradigm for quantitative understanding of hemostasis

  2016cites this paper
• Hematological spectrum in patients with alcoholic liver cirrhosis: a model of end-stage liver disease score based approach

  2016cites this paper
• Population Pharmacokinetic and Pharmacodynamic Modeling of Lusutrombopag, a Newly Developed Oral Thrombopoietin Receptor Agonist, in Healthy Subjects

  2016cites this paper
• The Eltrombopag antitumor effect on hepatocellular carcinoma

  2015cites this paper
• The thrombopoietin receptor P106L mutation functionally separates receptor signaling activity from thrombopoietin homeostasis.

  2015cites this paper
• Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide

  2015cites this paper
• The pharmacology and clinical application of thrombopoietin receptor agonists

  2014cites this paper
• Signal Transduction of Platelet-Induced Liver Regeneration and Decrease of Liver Fibrosis

  2014cites this paper
• Role of platelets in chronic liver disease and acute liver injury

  2014cites this paper
• Abnormal platelet kinetics are detected before the occurrence of thrombocytopaenia in HBV‐related liver disease

  2014cites this paper
• Does thrombopoiesis in multiple myeloma patients depend on the stage of the disease?

  2014cites this paper
• Eltrombopag in patients with chronic hepatitis C and thrombocytopenia

  2014cites this paper
• [The formation, metabolism and the evolution of blood platelets].

  2014cites this paper
• Eltrombopag in patients with chronic liver disease

  2013cites this paper
• Inhibition of Megakaryocyte Development in the Bone Marrow Underlies Dengue Virus-Induced Thrombocytopenia in Humanized Mice

  2013cites this paper
• A new role for tissue-type plasminogen activator in liver injury

  2013cites this paper
• Platelet turnover in atherothrombotic disease.

  2012influential citation
• Hematologic Safety of Breast Cancer Chemotherapies in Patients with Hepatitis B or C Virus Infection

  2012cites this paper
• Signals and Cells Involved in Regulating Liver Regeneration

  2012cites this paper
• Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?

  2011cites this paper
• Platelet production and destruction in liver cirrhosis.

  2011cites this paper
• Thrombopoietic cytokines and platelet count in multiple myeloma

  2010cites this paper
• THE ROLE OF PLATELETS IN OVARIAN CARCINOMA

  2010cites this paper
• Thrombopoietic agents.

  2010cites this paper
• Thrombocytopenia in Patients With Chronic Hepatitis C: A Possible Role of HCV on Platelet Progenitor Cell Maturation

  2010influential citation
• Étude de l’effet des médicaments antiplaquettaires sur la fonction plaquettaire : de la variabilité de réponse à l’effet rebond

  2010cites this paper
• New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses

  2009cites this paper
• Eltrombopag: the discovery of a second generation thrombopoietin-receptor agonist

  2009cites this paper
• Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.

  2009cites this paper
• A Review on the Use of Eltrombopag in Patients with Advanced Liver Disease

  2009cites this paper
• New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses.

  2009cites this paper
• Morpholino oligomers targeting the PB1 and NP genes enhance the survival of mice infected with highly pathogenic influenza A H7N7 virus.

  2008cites this paper
• Thrombopoietin is a growth factor for rat hepatic progenitors

  2008cites this paper
• Eltrombopag: Is this “24 karat gold platelet” treatment for thrombocytopenia in cirrhosis associated with hepatitis C?

  2008cites this paper
• Grundlagen des Überlebens von Plasmazellen im autoimmunen (NZBxNZW)F1 Mausmodell des Systemischen Lupus Erythematodes

  2008cites this paper
• Thrombopoietin level in patients with chronic liver diseases.

  2008cites this paper
• Thrombopoietin inhibits nerve growth factor-induced neuronal differentiation and ERK signalling.

  2008cites this paper
• Review article: blood platelet number and function in chronic liver disease and cirrhosis

  2008cites this paper
• Pengaruh Latihan Aerobik Intensitas Ringan dan Sedang terhadap Jumlah Trombosit pada Remaja Putri di Universitas Prima Indonesia Tahun 2008

  2008cites this paper
• Thrombopoietin or interleukin-6 has no effect on thrombocytopenia of cirrhosis.

  2007cites this paper
• Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.

  2007cites this paper
• Pharmacokinetic/pharmacodynamic modeling of IVIG effects in a murine model of immune thrombocytopenia.

  2007cites this paper
• Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options

  2006cites this paper
• The uORF-containing thrombopoietin mRNA escapes nonsense-mediated decay (NMD)

  2006cites this paper
• A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain.

  2005cites this paper
• Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients

  2004cites this paper
• Effect of altitude on thrombopoietin and the platelet count in healthy volunteers

  2004cites this paper
• Elevated thrombopoietin levels and alterations in the sequence of its receptor, c-Mpl, in patients with Diamond-Blackfan anemia.

  2004cites this paper
• Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease

  2004cites this paper
• Combined thrombopoietin and platelet response to altitude in a patient with autoimmune thrombocytopenia

  2004cites this paper
• Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection

  2003cites this paper
• Thrombopoietin production in human hepatic cell cultures (HepG2) is resistant to IFN-alpha, IFN-beta, and IFN-gamma treatment.

  2002cites this paper
• Review: Role of Blood Platelets in Infection and Inflammation

  2002cites this paper
• Short Communication: Thrombopoietin Production in Human Hepatic Cell Cultures (HepG2) Is Resistant to IFN-α, IFN-β, and IFN-γ Treatment

  2002cites this paper
• Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis.

  2002cites this paper
• Evaluation of the herbal formulation HPH-031508PP in mitigating complications associated with dengue in experimental studies

  year unknowncites this paper